Nitric Oxide Primes Pancreatic β Cells for Fas-mediated Destruction in Insulin-dependent Diabetes Mellitus

Fas is an apoptosis-inducing surface receptor involved in controlling tissue homeostasis and function at multiple sites. Here we show that β cells from the pancreata of newly diagnosed insulin-dependent diabetes mellitus (IDDM) patients express Fas and show extensive apoptosis among those cells located in proximity to Fas ligand–expressing T lymphocytes infiltrating the IDDM islets. Normal human pancreatic β cells that do not constitutively express Fas, become strongly Fas positive after interleuken (IL)-1β exposure, and are then susceptible to Fas-mediated apoptosis. NG-monomethyl-l-arginine, an inhibitor of nitric oxide (NO) synthase, prevents IL-1β–induced Fas expression, whereas the NO donors sodium nitroprusside and nitric oxide releasing compound (NOC)-18, induce functional Fas expression in normal pancreatic β cells. These findings suggest that NO-mediated upregulation of Fas contributes to pancreatic β cell damage in IDDM.

[1]  M. Zupancic,et al.  Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. , 1997, Science.

[2]  C. Janeway,et al.  The Role of Fas in Autoimmune Diabetes , 1997, Cell.

[3]  M. Todaro,et al.  Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis , 1997, Science.

[4]  M. Kurrer,et al.  Beta cell apoptosis in T cell-mediated autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  E. Unanue.  b cell apoptosis in T cell-mediated autoimmune diabetes , 1997 .

[6]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[7]  B. Roep.  T-Cell Responses to Autoantigens in IDDM: The Search for the Holy Grail , 1996, Diabetes.

[8]  A. Abbas,et al.  Role of Fas-mediated cell death in the regulation of immune responses. , 1996, Current opinion in immunology.

[9]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[10]  W. Suarez-Pinzon,et al.  Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets. , 1996, Endocrinology.

[11]  P. Krammer.  The CD95(APO-1/Fas) receptor/ligand system: death signals and diseases. , 1996, Cell death and differentiation.

[12]  A. Abbas,et al.  Die and Let Live: Eliminating Dangerous Lymphocytes , 1996, Cell.

[13]  J. Tschopp,et al.  Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. , 1996, Journal of Clinical Investigation.

[14]  M. Todaro,et al.  Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow-cytometry and cultured in vitro. , 1995, Transplantation proceedings.

[15]  H. Kolb,et al.  Autoimmune versus inflammatory type I diabetes: a controversy? , 1995, Immunology today.

[16]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[17]  S. Nagata,et al.  Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver , 1995, Nature Genetics.

[18]  B. Conrad,et al.  Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology , 1994, Nature.

[19]  J. Tschopp,et al.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.

[20]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[21]  K. Koretz,et al.  Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[22]  M. Mcdaniel,et al.  Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. , 1992, The Journal of clinical investigation.

[23]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[24]  M. Trucco,et al.  To Be Or Net To Be ASP 57, That Is The Question , 1992, Diabetes Care.

[25]  H. Kolb,et al.  Nitric oxide: a pathogenetic factor in autoimmunity. , 1992, Immunology today.

[26]  C. Nathan,et al.  Identification of arginine as a precursor of endothelium-derived relaxing factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Moncada,et al.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. , 1988, Biochemical and biophysical research communications.

[28]  D. Monos,et al.  Insulin dependent diabetes mellitus as an autoimmune disease. , 1988, In vivo.